## 

## 



## 

## 

||Page|
|---|---|
|Report of the Trustees|1 to 7|
|Report of the Independent Auditors|8 to 10|
|Statement of Financial Activities|11|
|Statement of Financial Position|12|
|Statement of Cash Flows|13|
|Notes to the Statement of Cash Flows|14|
|Notes to the Financial Statements|15 to 24|
|Detailed Statement of Financial Activities|25 to 26|





## 

## 

## 

## 

|**Appeal**|**Equipment**|**Hospital**|**Price**(£)|
|---|---|---|---|
|Bucks MRI Appeal|MRI Scanner|Stoke Mandeville|£450,000|
|Bucks MRI Appeal|Contrast Injector|Stoke Mandeville|£19,679|
|Bucks MRI Appeal|Injection Trolley|Stoke Mandeville|£1,160|
|Bucks MRI Appeal|Anaesthetic Monitor|Stoke Mandeville|£45,500|
|Bucks MRI Appeal|Patient Stretcher|High Wycombe|£6,000|
|Bucks MRI Appeal|Anaesthetic Monitor|High Wycombe|£45,500|
|Best for Bucks|Dexa Scanner|Amersham|£81,984|
|Best for Bucks|ChloroChek|Stoke Mandeville|£8,550|
|||TOTAL|**£658,373**|





## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

|||**Starting**|**Total net**||**Paid to**|**In the**|**Left to**|
|---|---|---|---|---|---|---|---|
|**Appeal**|**Target**|**Balance**|**income**|**Transfer**|**the NHS**|**fund**|**raise**|
||£|£|£|£|£|£|£|
|**MRI Appeal***|1,160,000|651,318|24,047|(194)|(561,839)|113,332|-|
|**Cardiac Appeal**|125,000|18,784|60,902|(9,306)|-|70,380|54,620|
|**Robot Appeal**|1,000,000||158,907|591,890|(96,534)|654,263|249,203|
|**Best for Bucks**|-|199,364||||199,364|-|
|**Sustainability**||120,000|-|-||120,000||
|IT**improvement**||2,785||22,215||25,000|-|
|**Total**||||||||
|**designated**|**2,285,000**|**992,251**|**243,856**|**604,605**|**(658,373)**|**1,182,339**|**303,823**|



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

|||||**2022**|2021|
|---|---|---|---|---|---|
|||Unrestricted||Total|Total|
|||funds|Designated|funds|funds|
||Notes|£|**£**|**£**|**£**|
|**INCOME AND ENDOWMENTS FROM**||||||
|Donations and legacies|3|797,235|18,211|815,446|937,792|
|Other trading activities|4|295,893|48,922|344,815|273,460|
|Investment income|5|2,262||2,262|2,857|
|Other income|||||14,120|
|Total||1,095,390|67,133|1,162,523|1,228,229|
|**EXPENDITURE ON**||||||
|Fund raising expenditure|6|125,130|1,863|126,993|144,709|
|Charitable activities|7|||||
|Funding of equipment||116,213|542,160|658,373|318,375|
|Governance costs||6,160|-|6,160|5,940|
|Office costs||125,882||125,882|104,769|
|Finance costs||4,866||4,866|6,163|
|Total||378,251|544,023|922,274|579,956|
|**NET INCOME/(EXPENDITURE)**||717,139|(476,890)|240,249|648,273|
|**Transfers between funds**|15|(12,715)|12,715|||
|Net movement**in funds**||704,424|(464,175)|240,249|648,273|
|**RECONCILIATION OF FUNDS**||||||
|**Total funds brought forward**||672,232|992,251|1,664,483|1,016,210|
|TOTAL**FUNDS CARRIED FORWARD**||1,376,656|528,076|1,904,732|1,664,483|





## 

||||2022|2021|
|---|---|---|---|---|
||Unrestricted||Total|Total|
||funds|Designated|funds|funds|
||Notes<br>£|**£**|**£**|**£**|
|**CURRENT ASSETS**|||||
|Stocks|12<br>898||898|704|
|Debtors|13<br>312,276||312,276|388,883|
|Cash at bank and in hand|1,089,827|528,076|1,617,903|1,291,119|
||1,403, 001|528,076|1,931, 077|1,680,706|
|**CREDITORS**|||||
|Amounts falling due within one year|14<br>(26,345)||(26,345)|(16,223)|
|**NET CURRENT ASSETS**|1,376,656|528,076|1,904,732|1,664,483|
|**TOTAL ASSETS LESS CURRENT**|||||
|**LIABILITIES**|1,376,656|528,076|1,904,732|1,664,483|
|**NET ASSETS**|1,376,656|528,076|1,904,732|1,664,483|
|**FUNDS**|15||||
|Unrestricted funds|||1,904,732|1,664,483|
|TOTAL FUNDS|||1,904,732|1,664,483|






## 

|||2022|2021|
|---|---|---|---|
||Notes|£|£|
|Cash flows**from operating activities**||||
|Cash generated from operations|1|324,522|259,678|
|Net cash provided by operating activities||324,522|259,678|
|Cash flows**from investing activities**||||
|Interest received||2,262|2,857|
|Net cash provided by investing activities||2,262|2,857|
|Change in cash and cash equivalents||||
|in the reporting**period**||326,784|262,535|
|**Cash and cash**equivalents at**the**||||
|**beginning of the reporting period**||1,291,119|1,028, 584|
|**Cash and cash**equivalents at the**end**||||
|**of the reporting period**||1,617,903|1,291,119|





## 

|**1.**|**RECONCILIATION OF NET INCOME**TO NET CASH FLOW FROM OPERATING ACTIVITIES|**RECONCILIATION OF NET INCOME**TO NET CASH FLOW FROM OPERATING ACTIVITIES|**RECONCILIATION OF NET INCOME**TO NET CASH FLOW FROM OPERATING ACTIVITIES|**RECONCILIATION OF NET INCOME**TO NET CASH FLOW FROM OPERATING ACTIVITIES|
|---|---|---|---|---|
||||2022|2021|
||||£|£|
||**Net income for the reporting period (as per the**|**Statement of**|||
||**Financial Activities)**||240,249|648,273|
||Adjustments for:||||
||Interest received||(2,262)|(2,857)|
||(Increase)/decrease in stocks||(194)|1,376|
||Decrease/(increase) in debtors||76,607|(381,033)|
||Increase/(decrease) in creditors||10,122|(6,081)|
||**Net cash provided by operations**||324,522|259,678|
|2.|**ANALYSIS OF CHANGES IN NET FUNDS**||||
|||At 1.4.21|Cash flow|At 31.3.22|
||Net cash||||
||Cash at bank and in hand|1,291,119|326,784|1,617,903|
|||1,291,119|326,784|1,617,903|
||Total|1,291,119|326,784|1,617,903|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

|**DONATIONS AND LEGACIES**|||
|---|---|---|
||2022|2021|
||£|£|
|Donations|132,889|181,241|
|Gift aid|30,930|60,194|
|Legacies|651,627|696,357|
||815,446|937,792|
|**OTHER TRADING ACTIVITIES**|||
||2022|2021|
||£|£|
|Fundraising activities|308,245|253,947|
|Bookshop, christmas cards and merchandise|36,570|19,513|
||344,815|273,460|





## 

## 

|**5.**|**INVESTMENT INCOME**||
|---|---|---|
|||2022<br>2021|
|||££|
||Deposit account interest|2,262<br>2,857|
|**6.**|**FUND RAISING EXPENDITURE**||
||**Raising donations and legacies**||
|||2022<br>2021|
|||££|
||Staff costs|84,443<br>87,822|
||Event and appeal costs|42,550<br>56,887|
|||126,993<br>144,709|



## 

|**CHARITABLE ACTIVITIES COSTS**||
|---|---|
||Grant|
||funding of|
||activities<br>Support|
||(see note<br>costs (see|
||8)note 9)<br>Totals|
||£££|
|Funding of equipment|658,373-<br>658,373|
|Governance costs|6,160<br>6,160|
|Office costs|125,882<br>125,882|
|Finance costs|-<br>4,866<br>4,866|
||658,373<br>136,908<br>795,281|
|**GRANTS PAYABLE**||
||2022<br>2021|
||££|
|Funding of equipment|658,373<br>318,375|
|The total grants paid to institutions during the year was as follows:||
||2022<br>2021|
||££|
|Breast Biopsy Appeal|-<br>318,375|
|MRI Appeal|561,839|
|Surgical Robot Appeal Fund|96,534|
||658,373<br>318,375|



## 



## 

## 

|**SUPPORT COSTS**|||||
|---|---|---|---|---|
||Office||Governance||
||costs|Finance|costs|Totals|
||£|£|£|£|
|Governance costs|-||6,160|6,160|
|Office costs|125,882|||125,882|
|Finance costs||4,866||4,866|
||125,882|4,866|6,160|136,908|



## 

||**Office**|**Governance**|||**Basis of**|
|---|---|---|---|---|---|
||**costs**|**costs**|**2022**|**2021**|**allocation**|
||£|£|£|£||
|Audit costs|-|6,160|6,160|5,940|Actual basis|
|Wages and salaries|98,123||98,123|89,255|Time spent|
|Other office costs|32,625||32,625|21,677|Actual basis|
||130,748|6,160|136,908|116,872||



## 

## 

## 

|**STAFF COSTS**|||
|---|---|---|
||2022|2021|
||£|£|
|Wages and salaries|162,373|158,439|
|Social security costs<br>Other pension costs|10,435<br>9,758|9,959<br>8,679|
||182,566|177,077|



## 

|**Transactions with key management personnel**|||
|---|---|---|
||2022|2021|
||£|£|
|Total compensation of key management personnel|40,326|32,917|





## 

## 

|11.|STAFF**COSTS - continued**||
|---|---|---|
||The average monthly number of employees during the year was as follows:||
|||2022<br>2021|
||Administration|33|
||Fundraisers|33|
|||66|
||No employees received emoluments in excess of £60,000.||
|**12.**|**STOCKS**||
|||2022<br>2021|
||Stocks|898704|
|**13.**|**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**||
|||2022<br>2021|
||Trade debtors|2643|
||Other debtors|17,506<br>21,467|
||Prepayments and accrued income|294,744<br>367,373|
|||312,276<br>388,883|
|**14.**|**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**||
|||2022<br>2021|
|||££|
||Social security and other taxes|5,490<br>3,889|
||Accruals and deferred income|20,855<br>12,334|
|||26,345<br>16,223|
||Included within accruals and deferred income is the following deferred income:||
||Deferred income at 31 March 2021|2,098|
||Released in the year|(2,098)|
||Deferred in the year|9,685|
||Deferred income at 31 March 2022|9,685|





## 

|**15.**<br>**MOVEMENT IN FUNDS**|||||
|---|---|---|---|---|
|||Net|Transfers||
|||movement|between|At|
||At 1.4.21|in funds|funds|31.3.22|
||£|£|£|£|
|**Unrestricted funds**|||||
|General fund|672,232|654,766|(604,605)|722,393|
|Designated IT Improvement Fund|2,785||22,215|25,000|
|Designated Sustainability Fund|120,000||-|120,000|
|MRI Appeal|651,318|(537,792)|(194)|113,332|
|Cardiac Appeal|18,784|60,902|(9,306)|70,380|
|Best for Bucks|199,364||-|199,364|
|Surgical Robot Appeal Fund||62,373|591,890|654,263|
||1,664,483|240,249||1,904,732|
|**TOTAL FUNDS**|1,664,483|240,249|-|1,904,732|



||Incoming|Resources|Movement|
|---|---|---|---|
||resources|expended|in funds|
||£|£|£|
|**Unrestricted funds**||||
|General fund|932,400|(277,634)|654,766|
|MRI Appeal|4,368|(542,160)|(537,792)|
|Cardiac Appeal|62,765|(1,863)|60,902|
|Surgical Robot Appeal Fund|162,990|(100,617)|62,373|
||1,162,523|(922,274)|240,249|
|**TOTAL FUNDS**|1,162,523|(922,274)|240,249|



## 

|||Net|Transfers||
|---|---|---|---|---|
|||movement|between|At|
||At 1.4.20|in funds|funds|31.3.21|
||£|£|£|£|
|**Unrestricted funds**|||||
|General fund|175,774|688,520|(192,062)|672,232|
|Eye See Appeal||1,000|(1,000)||
|Small Projects<br>Designated IT Improvement Fund|3,217|688<br>(432)|(688)|2,785|
|Designated Sustainability Fund|120,000|-||120,000|
|Breast Biopsy Appeal|285,127|(279,513)|(5,614)||
|MRI Appeal<br>Cardiac Appeal<br>Best for Bucks|432,092|219,226<br>18,784|199,364|651,318<br>18,784<br>199,364|
||1,016,210|648,273||1,664,483|
|TOTAL FUNDS|1,016,210|648,273||1,664,483|





## 

## 

||Incoming|Resources|Movement|
|---|---|---|---|
||resources|expended|in funds|
||£|£|£|
|**Unrestricted funds**||||
|General fund|913,381|(224,861)|688,520|
|Eye See Appeal|1,000|-|1,000|
|Small Projects|1,000|(312)|688|
|Designated IT Improvement Fund|-|(432)|(432)|
|Breast Biopsy Appeal|40,967|(320,480)|(279,513)|
|MRI Appeal|249,594|(30,368)|219,226|
|Cardiac Appeal|22,287|(3,503)|18,784|
||1,228,229|(579,956)|648,273|
|**TOTAL FUNDS**|1,228,229|(579,956)|648,273|





## 

## 

|CAPITAL**COMMITMENTS**||
|---|---|
||2022<br>2021|
||££|
|Contracted but not provided for in the financial statements|42,396<br>700,495|



## 



## 

## 

## 



## 

||2022|2021|
|---|---|---|
||£|£|
|**INCOME AND ENDOWMENTS**|||
|**Donations and legacies**|||
|Donations|132,889|181,241|
|Gift aid|30,930|60,194|
|Legacies|651,627|696,357|
||815,446|937,792|
|**Other trading activities**|||
|Fundraising activities|308,245|253,947|
|Bookshop, christmas cards and|||
|merchandise|36,570|19,513|
||344,815|273,460|
|Investment income|||
|Deposit account interest|2,262|2,857|
|**Other income**|||
|Furlough income||14,120|
|**Total incoming resources**|1,162,523|1,228,229|
|**EXPENDITURE**|||
|**Raising donations and legacies**|||
|Wages|79,246|82,682|
|Social security|5,197|5,140|
|Event and appeal costs|42,550|56,887|
||126,993|144,709|
|Charitable activities|||
|Grants to institutions|658,373|318,375|
|Support costs|||
|Office costs|||
|Wages|83,127|75,757|
|Social security|5,238|4,819|
|Pensions|9,758|8,679|
|Insurance|2,705|2,129|
|Telephone<br>Postage and stationery<br>Sundries|211<br>1,232<br>1,584|242<br>1,886<br>482|
|Accountancy<br>Travel and subsistence|6,546<br>738|6,275<br>172|
|Carried forward|111,139|100,441|





## 

## 

||2022|2021|
|---|---|---|
|**Office costs**|||
|Brought forward|111,139|100,441|
|Staff Recruitment|5,859||
|Volunteers costs|910|70|
|Computer costs|7,081|3,944|
|Legal costs|893|314|
||125,882|104,769|
|Finance|||
|Bank charges|4,866|6,163|
|**Governance costs**|||
|Auditors' remuneration|6,160|5,940|
|Total resources expended|922,274|579,956|
|Net income|240,249|648,273|



